32. Witteles RM, Kaplan EL, Roizen MF. Sensitivity of diagnostic and localization tests for pheochromocytoma in clinical practice. Arch Intern Med. 2000; 160:2521-4.
33. Van der Harst E, De Herder WW, Bruining HA, Bonjer HJ, De Krijger RR, Amberts SW, et al. [123I]Metaiodobenzylguanidine and [111In]octeotride uptake in benign and malignant pheo-chromocytomas. J Clin Endocrinol Metab. 2001; 86:685-93.
34. Shulkin BL, Thompson NW, Shapiro B , Francis IR, Sisson JC. Pheochromocytomas: ima-ging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET. Radiology. 1999; 212:35-41.
35. Mamede M, Carrasquillo JA, Chen CC, et al. Discordant localization of 2-[18F]-fluorodopa-mine- and [(123I)]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites. Nu-cl Med Commun. 2006; 27:31-6.
36. Epelbaum J, Bertherat J, Prevost G, Kordon C, Meyerhof W, Wulfsen I, et al. PF Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, entraadrenal, and malignant pheochromocytomas. J Clin Endocrinol Metab. 1995; 80:1837-44.
37. Vanhagen PM, Krenning EP, Reubi J, Kwekkeboom DJ, Bakker WH, Mulder AH, et al. So-matostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med. 1994; 21:497-502.
38. Khafagi FA, Shapiro B, Fig LM, Mallete S, Sisson JC. Labetalol reduces 123I-MIBG uptake by pheochromocytoma and normal tissues. J Nucl Med. 1989; 30:481-9.
39. Vanderveen KA, Thompson SM, Callstrom MR, et al. Biopsy of pheochromocytomas and paragangliomas: potential for disaster. Surgery. 2009; 146(6):1158-66.
40. Kinney MA, Warner ME, Van Heerden JA, Horlocker TT, Young WF Jr, Schroeder DR, et al. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. A-nesth Analg. 2000; 91:1118-23.
41. Prys-Roberts C, Farndon JR. Efficacy and safety of doxazosine for perioperative manage-ment of patients with pheochromocytoma. World J Surg. 2002; 26:1037-42.
42. Hoffman BB. Catecholamines, sympathomimetic drugs, and adrenergic receptor antago-nists. In: Hardman JG, Limbird LE, eds. Goodman & Gillman´s The Pharmacological Basis of Therapeutics. Philadelphia; McGraw-Hill; 2001:215-68.
43. Kocak S, Aydintug S, Canakci N. Alpha blockade in preoperative preparation of patients with pheochromocytomas. Int Surg. 2002; 87:191-4.
44. Briggs RS, Birtwell AJ, Pohl JE. Hypertensive response to labetalol in phaeochromocytoma. Lancet. 1978; 1:1045-6
45. Combemale F, Carnaille B, Tavernier B, et al. Exclusive use of calcium channel blockers and cardioselective beta-blockers in the pre-and per-operative management of pheochromocyto-mas. 70 cases [in French]. Ann Chir. 1998; 52:341-5.
46. Ulchaker JC, Goldfarb DA, Bravo EL, Novick AC. Succesful outcomes in pheochromocyto-ma surgery in the modern era. J Urol. 1999; 161:764-7.
47. Perry RR, Keiser HR, Norton JA, et al. Surgical management of pheochromocytoma with the use of metyrosine. Ann Surg. 1990; 212:621-8.
48. Melmed S, Polonsky KS, Reed Larsen P, Kronenberg HM. Williams Textbook of Endocri-nology. 12th. ed. Philadelphia, PA: Elsevier; 2011.
49. Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007; 92:4069-79.
50. Shen WT, Grogan R, Vriens M, Clark OH, Duh QY. One hundred two patients with pheo-chromocytoma treated at a single institution since the introduction of laparoscopic adrenalecto-my. Arch Surg. 2010; 145:893-7.
51. Argawal G, Sadacharan D, Aggarwal V, et al. Surgical management of organ-contained uni-lateral pheochromocytoma: comparative outcomes of laparoscopic and conventional open surgi-cal procedures in a large single-institution series. Langenbecks Arch Surg. 2012; 397:1109-16.
52. Brunaud L, Ayav A, Zarnegar R, et al. Prospective evaluation of 100 robotic-assisted unila-teral adrenalectomies. Surgery. 2008; 144:995-1001.
53. Iihara M, Suzuki R, Kawamata A, et al. Adrenal-preserving laparoscopic surgery in selected patients with bilateral adrenal tumors. Surgery. 2003; 134:1066-72.
54. Fernández-Cruz L, Taura P, Sáenz A. Laparoscopic approach to pheochromocytoma: he-modinamic changes and catecholamine secretion. World J Surg. 1996; 20:762-8.
55. Kinney MA, Narr BJ, Warner MA. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth. 2002; 16:359-69.
56. Wängberg B, Muth A, Khorram-Manesh A, et al. Malignant pheochromocytoma in a popu-lation-based study: survival and clinical results. Ann NY Acad Sci. 2006; 1073:512-6.
57. Amar L, Fassnacht M, Giménez-Roqueplo AP, et al. Long-term postoperative follow-up in patients with apparently benign pheochromocytoma and paraganglioma. Horm Metab Res. 2012; 44:385-9.
58. Buffet A, Venisse A, Nau V, et al. A decade (2001-2010) of genetic testing for pheochromo-cytoma and paraganglioma. Horm Metab Res. 2012; 44:359-66.
59. Dahia PLM. Evolving concepts in pheochromocytoma and paraganglioma. Curr Opin Oncol. 2006; 18:1-8.
60. Schussheim DH, Skarulis MC, Agarwal SK. Multiple endocrine neoplasia type 1: new clini-cal and basic findings. Trends Endocrinol Metab. 2001; 12:173-8.
61. Raue F, Frank-Raue K, Grauer A. Multiple endocrine neoplasia type 2: clinical features and screening. Endocrinol Metab Clin North Am. 1994; 23:137-56.
62. Machens A, Brauckhoff M, Hans-Jurgen H, Phuong Nguyen T, Hendrik L, Henning D. Co-don specific development of pheochromocytoma in multiple endocrine neoplasia type-2. J Clin Endocr Metab. 2005; 90:3999-4003.
63. Eisenhofer G, Walther MM, Huynh TT, Li ST, Bornstein S R, Vortmeyer A, et al. Pheo-chromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 dis-play distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab. 2001; 86: 1999-2008.
64. Walther MM, Herring J, Enquist E, Keiser HR, Linehan WM. Von Recklinghausen´s di-sease and pheochromocytomas. J Urol. 1999; 162:1582-6.
65. Lyman DJ. Paroxismal hypertension, pheochromocytoma and pregnancy. J Am Board Fam Pract. 2002; 15:153-8.
66. Keely E. Endocrine causes of hypertension in pregnancy. When to start looking for zebras? Semin Perinatol. 1998; 22:471-84.
67. Grodski S, Jung O, Kertes P, Davies M, Banting S. Pheochromocytoma with pregnancy. Int Med J. 2006; 36:604-6.
68. Kalra JK, Jain V, Bagga R, Gopalan S, Bhansali AK, Behera A, et al. Pheochromocytoma associated with pregnancy. J Obstet Gynaecol Res. 2003; 29:305-8.